MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors

Advances in the use of targeted and immune therapies have revolutionized the clinical management of melanoma patients, prolonging significantly their overall and progression-free survival. However, both targeted and immune therapies suffer limitations due to genetic mutations and epigenetic modifica...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Maria Letizia Motti, Michele Minopoli, Gioconda Di Carluccio, Paolo Antonio Ascierto, Maria Vincenza Carriero
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI AG 2020-06-01
סדרה:International Journal of Molecular Sciences
נושאים:
miRNA
melanoma
melanoma resistance to MAPK/MEK inhibitors
resistance to immune checkpoint inhibitors
גישה מקוונת:https://www.mdpi.com/1422-0067/21/12/4544
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים